Signaling pathways in obesity: mechanisms and therapeutic interventions.
Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R, Xu X, Li T. · 2022
Read Signaling pathways in obesity: mechanisms and therapeutic interventions. by Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R, Xu X, Li T. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9420733.txt.
Description
Wen and co-authors map the signaling pathways that drive obesity and the drugs that target them. Obesity is a chronic disease marked by excess body fat. It raises the risk of type 2 diabetes, heart disease, and fatty liver disease. Diet and exercise help, but lasting weight loss stays hard.
The review covers pathways that govern food intake and glucose balance. Others shape fat cell growth, heat output, and chronic inflammation. Named routes include MAPK, PI3K/AKT, JAK/STAT, and AMPK. A second half turns to treatment. It surveys approved anti-obesity drugs and compounds in clinical trials. GLP-1 based drugs get close attention. The authors frame pathway knowledge as a path to precise care.
Catalog record
| CREATOR | Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R, Xu X, Li T. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 230 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |